Adenosine-induced cardiac pause for endovascular embolization of cerebral arteriovenous malformations: technical case report.
OBJECTIVE
Extremely high flow through arteriovenous malformations (AVMs) may limit the safety and effectiveness of endovascular glue therapy. To achieve a more controlled deposition of glue, we used transient but profound systemic hypotension afforded by an intravenously administered bolus of adenosine to induce rapidly reversible high-degree atrioventricular block.


METHODS
A patient with a large high-flow occipital AVM fed primarily by the posterior cerebral artery underwent n-butyl cyanoacrylate glue embolization. Nitroprusside-induced systemic hypotension did not adequately reduce flow through the nidus, as determined by contrast injection in the feeding artery. In a dose-escalation fashion, boluses of adenosine were administered to optimize the dose and verify that there was no flow reversal in the AVM and no other unexpected hemodynamic abnormalities by arterial pressure measurements and transcranial Doppler monitoring of the posterior cerebral artery feeding the AVM. Thereafter, 64 mg of adenosine was rapidly injected as a bolus to provide 10 to 15 seconds of systemic hypotension (approximately 20 mm Hg). Although there were conducted beats and some residual forward flow through the AVM during this time, the mean systemic and feeding artery pressures were roughly similar and remained relatively constant. A slow controlled injection of n-butyl cyanoacrylate glue was then performed, with excellent filling of the nidus.


CONCLUSIONS
Adenosine-induced cardiac pause may be a viable method of partial flow arrest in the treatment of cerebral AVMs. Safe, deep, and complete embolization with a permanent agent may increase the likelihood of endovascular therapy's being curative or may further improve the safety of microsurgical resection.
Pile-Spellman
J
J
Department of Radiology, College of Physicians and Surgeons, Columbia University, New York, New York, USA.
Young
W L
WL
Joshi
S
S
Duong
H
H
Vang
M C
MC
Hartmann
A
A
Kahn
R A
RA
Rubin
D A
DA
Prestigiacomo
C J
CJ
Ostapkovich
N D
ND
D000241:Adenosine / Q000627:therapeutic use*; D000269:Adhesives; D000328:Adult; D004562:Electrocardiography; D004621:Embolization, Therapeutic; D004659:Enbucrilate; D005260:Female; D006327:Heart Block; D006801:Humans; D002538:Intracranial Arteriovenous Malformations / Q000628:therapy*
D000269:Adhesives; D004659:Enbucrilate; D000241:Adenosine